Major scientific discovery in cancer research to be honored

July 23, 2004

Scientists involved in cancer research, cancer medicine or cancer-related biomedical science can nominate a colleague or professional associate whom they believe has advanced significantly the understanding of cancer and whose work holds promise for future contributions for the field for the 8th Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research.

The nomination process and other details about the award located on the AACR Website at http://www.aacr.org. The deadline for nominations is Friday, September 17, 2004.

The award is intended to honor an individual scientist for his or her highly original research. In order to be eligible, candidates must be recently published, active researchers, working in academia, industry or government anywhere in the world.

The winner will give an award lecture during the 96th AACR Annual Meeting in Anaheim, Calif., April 16-20, 2005, and will officially receive the award of €75,000 and a commemorative plaque at a May 2005 ceremony in Trento, Italy, where the Pezcoller Foundation is located.

Past recipients of the Pezcoller Foundation-AACR International Award for Cancer Research are:

2004:
Stanley J. Korsmeyer, M.D.
Sidney Farber Professor of Pathology and Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass.
Investigator, Howard Hughes Medical Institute

2003:
Mario R. Capecchi, Ph.D.
Distinguished Professor and Co-chairman
Eccles Institute of Human Genetics
University of Utah, Salt Lake City

2002:
Carl-Henrik Heldin, Ph.D.
Director, Ludwig Institute for Cancer Research
Professor of Molecular Cell Biology
Uppsala University, Uppsala, Sweden
-end-
The Pezcoller Foundation was established in 1982 by Professor Alessio Pezcoller, a dedicated Italian surgeon who made important contributions to medicine during his career and who, through his foresight, vision, and generous gift in support of the formation of the Foundation, stimulated others to make significant advances in cancer research. The Foundation sponsors a series of symposia and publishes a journal. In the past, the Pezcoller Foundation gave a biennial award for contributions to cancer and cancer-related biomedical science in collaboration with the European School of Oncology. The Pezcoller Foundation-AACR International Award builds upon this tradition

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 22,000 laboratory and clinical scientists engaged in basic, translational, and clinical cancer research in the United States and over 60 other countries. The AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). The AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational, and clinical cancer research.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.